U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Science & Research
  3. Science and Research Special Topics
  4. Advancing Regulatory Science
  5. Priority Area 8: Strengthen Social and Behavioral Science to Promote Informed Decision-Making About FDA-Regulated Products
  1. Advancing Regulatory Science

Priority Area 8: Strengthen Social and Behavioral Science to Promote Informed Decision-Making About FDA-Regulated Products

Customers in pharmacy consulting smart phones; patient looking at medical product labelling, nurse explaining medication to elderly patient

One way that FDA protects the public from harm and promotes public health is by making sure you get accurate, science-based information to use the medicines and foods you need to get and stay well.

To translate science-based regulatory decisions and information into public health gains, FDA is working to:

  • identify gaps in key areas of knowledge and in reaching diverse audiences
  • evaluate the effectiveness of FDA's Risk Communication, and
  • integrate knowledge from research and evaluation into practice.

We do this by conducting research, encouraging extramural research, and seeking expert advice.

 

Extramural Research Funded through the BAA

  1. Supporting Innovation by Enhancing Regulatory Knowledge in Academia
  2. The National Medical Device Curriculum: Supporting Innovation by Enhancing Regulatory Knowledge in Academia
  3. Nurse Pain Educator Pilot Program (NPE)
  4. FDA Health Care Professional Communication Project
  5. Integrated Clinical Decision Support System to Advance the Safe Use of Antibiotics
  6. Pragmatic Risk Score for Severe Hypoglycemic Events
  7. Optimizing the Use of Opioid Therapy Following Surgery
  8. FDA Physician Communication Project: Testing with Professional Societies
  9. Evaluating the Impact of Flow Restrictors on Pediatric Exposures to Liquid Single Ingredient Acetaminophen
  10. Improving Safe Use of Fluoroquinolones Through Development of an Innovative Educational Program

 

Back to Top